75F40123F19025

FDA ENTERPRISE PERFORMANCE LIFE CYCLE (FDA EPLC) DEVELOPMENT, MODERNIZATION, AND ENHANCEMENT (DME) ACTIVITIES TO ENHANCE THE DRLM COMPONENT OF FURLS.

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	FDA OFFICE OF ACQ GRANT SVCS
NAICS	541511 — Custom Computer Programming Services
PSC	DF01 — Support services for IT Management to include Enterprise Architecture (EA), Financial Management, and Strategic Planning. EA includes services supporting business, information, application and technical architecture to drive standardization, integration and efficiency among business technology solutions. Financial Management includes services involved in the planning, budgeting, spend management and chargeback of IT expenditures and the costing of IT products and services. IT Management and Strategic Planning include senior professional and administrative support services facilitating centralized IT strategy and planning.
Parent award / vehicle	75F40120A00001
Set-aside	Not reported
Pricing type	LABOR HOURS
Obligations	$1.1M
Current contract value	$1.1M
Potential contract value / ceiling	$1.1M
Start date	Dec 15, 2022
Current end date	Jun 8, 2024
Potential end date	Jun 8, 2024
Latest award activity	Apr 15, 2025
Source loaded	Aug 15, 2026

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Apr 15, 2025	P00002	$-87	FDA ENTERPRISE PERFORMANCE LIFE CYCLE (FDA EPLC) DEVELOPMENT, MODERNIZATION, AND ENHANCEMENT (DME) ACTIVITIES TO ENHANCE THE DRLM COMPONENT OF FURLS. THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.